Business Context and Reporting Period
cbdMD, Inc. filed a Form 8-K Current Report on February 16, 2023. The company is incorporated in North Carolina and trades on the NYSE American under the symbols YCBD (common stock) and YCBDpA (8.0% Series A Cumulative Convertible Preferred Stock). The filing reports a corporate event regarding preferred stock dividends.
Key Financial Metrics
This filing does not contain comprehensive financial statements. The only specific financial metric disclosed is the declaration of a monthly cash dividend of $0.0667 per share for the 8.0% Series A Cumulative Convertible Preferred Stock. Revenue, profit, cash flow, margins, debt, and liquidity figures are not provided in this document.
Material Changes
The filing reports the declaration of a dividend rather than a change in financial performance. The dividend is payable on March 15, 2023, to holders of record as of March 1, 2023. No other material changes to the company's operations or financial position are detailed in this report.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. The document is limited to the notification of the dividend event under Item 8.01 Other Events.
Investor Verification Checklist
- Verify the record date of March 1, 2023, to confirm eligibility for the $0.0667 per share dividend.
- Confirm the payment date of March 15, 2023, for the Series A Convertible Preferred Stock.
- Review the company's most recent 10-Q or 10-K filings for comprehensive revenue, profit, and liquidity data, as this 8-K does not provide them.
- Check the status of the 8.0% Series A Cumulative Convertible Preferred Stock for any cumulative dividend arrears not mentioned in this specific declaration.